June 4, 2021

Press release

New Board member proposed and invitation for Extraordinary General Meeting

Copenhagen, Denmark, 4 June 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) proposes the election of Mats Thorén as new board... [Read more]

June 1, 2021

Press release

FluoGuide A/S – Flagging message

Copenhagen, Denmark, 1 June 2021, FluoGuide A/S (“FluoGuide” or “the Company”) hereby announce that Arbejdernes Landsbank has informed the Company that... [Read more]

May 28, 2021

Press release

FluoGuide issue warrants to employees, management, and Board of Directors

Copenhagen, Denmark, 28 May 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that based on the approved... [Read more]

May 26, 2021

Press release

FluoGuide A/S publishes interim report for the period January – March 2021

Copenhagen, Denmark, 26 May 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January... [Read more]

May 18, 2021

Press release

FluoGuide has received green light to proceed to the next dose level with FG001 in the ongoing clinical phase I/II trial in patients undergoing surgical treatment of high grade glioma

Copenhagen, Denmark, 18 May 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the dose escalation committee... [Read more]

May 12, 2021

Press release

FluoGuide has received approval to commence with FG001 in evening dosing in the ongoing clinical phase I/II trial in patients with high grade glioma

Copenhagen, Denmark, 12 May 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the Danish Medicines Agency... [Read more]

May 12, 2021

Press release

FluoGuide has completed a directed share issue raising SEK 75 million

Copenhagen, Denmark, 12 May 2021 – FluoGuide A/S (publ a developer of surgical precision solutions within oncology (“FluoGuide” or the “Company”)... [Read more]

May 11, 2021

Press release

FluoGuide intends to carry out a directed share issue of approximately SEK 75 million

Copenhagen, Denmark, 17:31 CEST, 11 May 2021 – FluoGuide A/S (publ), a developer of surgical precision solutions within oncology (“FluoGuide” or... [Read more]

April 8, 2021

Press release

FluoGuide has received green light to proceed to fifth dose level with FG001 in the ongoing clinical phase I/II trial in patients with high grade glioma

Copenhagen, Denmark, 8 April 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the dose escalation committee... [Read more]